Drug Profile
Fradafiban
Alternative Names: BIBU 52; BIBU 52 ZWLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Antiplatelets; Biphenyl compounds; Pyrrolidines; Small molecules
- Mechanism of Action Fibrinogen receptor antagonists; GPIIb-IIIa antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis; Unstable angina pectoris
Most Recent Events
- 13 Jun 2001 Discontinued-II for Thrombosis in Europe (IV)
- 13 Jun 2001 Discontinued-II for Unstable angina pectoris in Europe (IV)
- 13 Jun 2001 Discontinued-II for Unstable angina pectoris in USA (IV)